Second trimester two‐step trisomy 18 screening using maternal serum markers
Identifieur interne : 000F01 ( France/Analysis ); précédent : 000F00; suivant : 000F02Second trimester two‐step trisomy 18 screening using maternal serum markers
Auteurs : Françoise Muller [France] ; Corinne Sault [France] ; Catherine Lemay [France] ; Nathalie Roussel-Mizon [France] ; François Forestier [France] ; Jean-Louis Frendo [France]Source :
- Prenatal Diagnosis [ 0197-3851 ] ; 2002-07.
English descriptors
- KwdEn :
Abstract
Trisomy 21 maternal serum marker screening has led to screening for other anomalies, including trisomy 18. Trisomy 18 is generally prenatally diagnosed because of major morphological defects. However, in up to 30% of cases ultrasound signs are unclear, and in most cases diagnosis is performed late in pregnancy. Of the different maternal serum markers, PAPP‐A is now considered as the best for trisomy 18 screening. However, pregnancy‐associated plasma protein A (PAPP‐A) is of value in first trimester screening for trisomy 21, but not in the second trimester. We therefore propose a two‐step screening strategy. Based on 45 trisomy 18 cases, we confirm the values of alpha‐fetoprotein (AFP) (median 0.61 MoM), free β‐human chorionic gonadotrophin (β‐hCG) (median 0.24 MoM) and of PAPP‐A (median 0.08 MoM). In the first step, a 0.5 MoM cut‐off for AFP or for free β‐hCG resulted in detection of 37/45 trisomy 18 cases (82%) with a 10% false‐positive rate. The second step consisted of the measurement of PAPP‐A for all these false‐positive cases. Using a PAPP‐A cut‐off of 0.5 MoM, all the 37 trisomy 18 cases were detected, but now with a 0.1–0.2% false‐positive rate. Amniocentesis was only offered to these few patients. This two‐step second trimester screening will be of value for patients who have not been included in first trimester screening based on nuchal translucency (NT) measurement combined with the first trimester markers, PAPP‐A and free β‐hCG. Copyright © 2002 John Wiley & Sons, Ltd.
Url:
DOI: 10.1002/pd.345
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001014
- to stream Istex, to step Curation: 001014
- to stream Istex, to step Checkpoint: 000728
- to stream Main, to step Merge: 001630
- to stream Main, to step Curation: 001589
- to stream Main, to step Exploration: 001589
- to stream France, to step Extraction: 000F01
Links to Exploration step
ISTEX:2EF17DDACF1A661A4A3D416198A983B559B3FAF3Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Second trimester two‐step trisomy 18 screening using maternal serum markers</title><author><name sortKey="Muller, Francoise" sort="Muller, Francoise" uniqKey="Muller F" first="Françoise" last="Muller">Françoise Muller</name></author><author><name sortKey="Sault, Corinne" sort="Sault, Corinne" uniqKey="Sault C" first="Corinne" last="Sault">Corinne Sault</name></author><author><name sortKey="Lemay, Catherine" sort="Lemay, Catherine" uniqKey="Lemay C" first="Catherine" last="Lemay">Catherine Lemay</name></author><author><name sortKey="Roussel Izon, Nathalie" sort="Roussel Izon, Nathalie" uniqKey="Roussel Izon N" first="Nathalie" last="Roussel-Mizon">Nathalie Roussel-Mizon</name></author><author><name sortKey="Forestier, Francois" sort="Forestier, Francois" uniqKey="Forestier F" first="François" last="Forestier">François Forestier</name></author><author><name sortKey="Frendo, Jean Ouis" sort="Frendo, Jean Ouis" uniqKey="Frendo J" first="Jean-Louis" last="Frendo">Jean-Louis Frendo</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2EF17DDACF1A661A4A3D416198A983B559B3FAF3</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/pd.345</idno><idno type="url">https://api.istex.fr/document/2EF17DDACF1A661A4A3D416198A983B559B3FAF3/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001014</idno><idno type="wicri:Area/Istex/Curation">001014</idno><idno type="wicri:Area/Istex/Checkpoint">000728</idno><idno type="wicri:doubleKey">0197-3851:2002:Muller F:second:trimester:two</idno><idno type="wicri:Area/Main/Merge">001630</idno><idno type="wicri:Area/Main/Curation">001589</idno><idno type="wicri:Area/Main/Exploration">001589</idno><idno type="wicri:Area/France/Extraction">000F01</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Second trimester two‐step trisomy 18 screening using maternal serum markers</title><author><name sortKey="Muller, Francoise" sort="Muller, Francoise" uniqKey="Muller F" first="Françoise" last="Muller">Françoise Muller</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Service de Biochimie, Hôpital Ambroise Paré, Boulogne</wicri:regionArea><wicri:noRegion>Boulogne</wicri:noRegion><wicri:noRegion>Boulogne</wicri:noRegion></affiliation></author><author><name sortKey="Sault, Corinne" sort="Sault, Corinne" uniqKey="Sault C" first="Corinne" last="Sault">Corinne Sault</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire Marcel Mérieux, Lyon</wicri:regionArea><placeName><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Lemay, Catherine" sort="Lemay, Catherine" uniqKey="Lemay C" first="Catherine" last="Lemay">Catherine Lemay</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire d'ormonologie, Centre Hospitalier, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Roussel Izon, Nathalie" sort="Roussel Izon, Nathalie" uniqKey="Roussel Izon N" first="Nathalie" last="Roussel-Mizon">Nathalie Roussel-Mizon</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire d'ormonologie, Centre Hospitalier, Amiens</wicri:regionArea><placeName><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Forestier, Francois" sort="Forestier, Francois" uniqKey="Forestier F" first="François" last="Forestier">François Forestier</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Biologie Fœtale, Institut de Puériculture, Paris</wicri:regionArea><placeName><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Frendo, Jean Ouis" sort="Frendo, Jean Ouis" uniqKey="Frendo J" first="Jean-Louis" last="Frendo">Jean-Louis Frendo</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>INSERM, U427, Faculté de Pharmacie, Paris</wicri:regionArea><placeName><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Prenatal Diagnosis</title><title level="j" type="sub">Published in Affiliation With the International Society for Prenatal Diagnosis</title><title level="j" type="abbrev">Prenat. Diagn.</title><idno type="ISSN">0197-3851</idno><idno type="eISSN">1097-0223</idno><imprint><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2002-07">2002-07</date><biblScope unit="volume">22</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="605">605</biblScope><biblScope unit="page" to="608">608</biblScope></imprint><idno type="ISSN">0197-3851</idno></series><idno type="istex">2EF17DDACF1A661A4A3D416198A983B559B3FAF3</idno><idno type="DOI">10.1002/pd.345</idno><idno type="ArticleID">PD345</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0197-3851</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AFP</term><term>PAPP‐A</term><term>biochemical screening</term><term>free β‐hCG</term><term>prenatal screening</term><term>trisomy 18</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Trisomy 21 maternal serum marker screening has led to screening for other anomalies, including trisomy 18. Trisomy 18 is generally prenatally diagnosed because of major morphological defects. However, in up to 30% of cases ultrasound signs are unclear, and in most cases diagnosis is performed late in pregnancy. Of the different maternal serum markers, PAPP‐A is now considered as the best for trisomy 18 screening. However, pregnancy‐associated plasma protein A (PAPP‐A) is of value in first trimester screening for trisomy 21, but not in the second trimester. We therefore propose a two‐step screening strategy. Based on 45 trisomy 18 cases, we confirm the values of alpha‐fetoprotein (AFP) (median 0.61 MoM), free β‐human chorionic gonadotrophin (β‐hCG) (median 0.24 MoM) and of PAPP‐A (median 0.08 MoM). In the first step, a 0.5 MoM cut‐off for AFP or for free β‐hCG resulted in detection of 37/45 trisomy 18 cases (82%) with a 10% false‐positive rate. The second step consisted of the measurement of PAPP‐A for all these false‐positive cases. Using a PAPP‐A cut‐off of 0.5 MoM, all the 37 trisomy 18 cases were detected, but now with a 0.1–0.2% false‐positive rate. Amniocentesis was only offered to these few patients. This two‐step second trimester screening will be of value for patients who have not been included in first trimester screening based on nuchal translucency (NT) measurement combined with the first trimester markers, PAPP‐A and free β‐hCG. Copyright © 2002 John Wiley & Sons, Ltd.</div></front></TEI><affiliations><list><country><li>France</li></country><settlement><li>Amiens</li><li>Lyon</li><li>Paris</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Muller, Francoise" sort="Muller, Francoise" uniqKey="Muller F" first="Françoise" last="Muller">Françoise Muller</name></noRegion><name sortKey="Forestier, Francois" sort="Forestier, Francois" uniqKey="Forestier F" first="François" last="Forestier">François Forestier</name><name sortKey="Frendo, Jean Ouis" sort="Frendo, Jean Ouis" uniqKey="Frendo J" first="Jean-Louis" last="Frendo">Jean-Louis Frendo</name><name sortKey="Lemay, Catherine" sort="Lemay, Catherine" uniqKey="Lemay C" first="Catherine" last="Lemay">Catherine Lemay</name><name sortKey="Roussel Izon, Nathalie" sort="Roussel Izon, Nathalie" uniqKey="Roussel Izon N" first="Nathalie" last="Roussel-Mizon">Nathalie Roussel-Mizon</name><name sortKey="Sault, Corinne" sort="Sault, Corinne" uniqKey="Sault C" first="Corinne" last="Sault">Corinne Sault</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F01 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000F01 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:2EF17DDACF1A661A4A3D416198A983B559B3FAF3
|texte= Second trimester two‐step trisomy 18 screening using maternal serum markers
}}
| This area was generated with Dilib version V0.6.25. |  |